Global Blood Therapeutics Inc. (GBT) Return on Investment ROI from the second quarter of 2022 to second quarter of 2021 and for the year 2022, average high and low, overall ranking from Jun 30 2022 to Jun 30 2021 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Global Blood Therapeutics Inc.  (NASDAQ: GBT)


Global Blood Therapeutics's ROI from its second quarter of 2022 to the second quarter of 2021 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Global Blood Therapeutics's ROI in the second quarter of 2022?
Global Blood Therapeutics Inc. recorded a cumulative net loss of $-322 million during 12 months ending in the second quarter of 2022, resulting in a negative return on investment (ROI) of -43.69%.

Within the Healthcare sector 667 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2022 from 0 to 4595.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter
Y / Y Investment Change TTM 23.45 % 8.63 % -2.76 % -13.39 % -12.78 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 777 790 851 534 542
Return On Investment (TTM) -43.69 % -45.57 % -48.15 % -47.98 % -44.53 %
GBT's Overall Ranking # 4595 # 0 # 0 # 0 # 0
Seq. Investment Change TTM 8.65 % 7.92 % 8.92 % -3.33 % -4.4 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -322 -310 -303 -277 -266

GBT Company Profile >> Back to GBT Roi Comparisons >> See Annual GBT Return On Investment



Return On Investment GBT's Ranking
Within: No.
Industry # 285
Sector # 668
Overall # 4595

Return On Investment Statistics
High Average Low
-32.64 %
-39.64 %
-48.15 %
(Dec 31 2018)   (Dec 31 2021)







Financial Statements
Global Blood Therapeutics's II. Quarter Investments $ 777 Millions GBT's Balance sheet
Global Blood Therapeutics's II. Quarter Income $ -82 Millions Quarterly GBT's Income Statement
GBT's Income by Division See GBT's Income by Division


GBT Annual Return On Investment (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017
Total Investments in Millions 851 645 725 584 330
Y / Y Investment Growth 31.98 % -11 % 24.11 % 76.69 % 76.84 %
Net Income in Millions -303 -248 -267 -174 -117
Y / Y Net Income Growth - - - - -
Annual Return On Investment -35.61 % -38.38 % -36.81 % -29.83 % -35.41 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
GBT's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for GBT's Competitors
Subscribers only: Roi for Global Blood Therapeutics's Suppliers
Subscribers only: Return On Investment for GBT's Customers

Other Ratios
GBT's Roa GBT's Inventory Turnover Ratio GBT's Growth Rates GBT's Dividend Statistics
GBT's Profitability Ratios GBT's Asset Turnover Ratio GBT's Dividend Growth
GBT's Roe GBT's Valuation Ratios GBT's Financial Strength Ratios GBT's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2022, within Healthcare Sector ROI

Date modified: 2026-08-30T17:12:36+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.